No drug designed by artificial intelligence has won FDA clearance, and pharma leaders say biology is the obstacle. Silicon Valley promises AI will cure disease, but drugmaker CEOs aren’t buying it.
Source: Wall Street Journal US Business · Summarized by HeadlinesBriefing